Andy Pasternak

2019

In 2019, Andy Pasternak earned a total compensation of $2.9M as Executive Vice President, Chief Strategy Officer at Horizon Pharma.

Compensation breakdown

Bonus$500,000
Non-Equity Incentive Plan$97,050
Option Awards$1,099,996
Salary$108,333
Stock Awards$1,099,974
Other$19,188
Total$2,924,542

Pasternak received $1.1M in option awards, accounting for 38% of the total pay in 2019.

Pasternak also received $500K in bonus, $97.1K in non-equity incentive plan, $108.3K in salary, $1.1M in stock awards and $19.2K in other compensation.

Rankings

In 2019, Andy Pasternak's compensation ranked 4,190th out of 13,971 executives tracked by ExecPay. In other words, Pasternak earned more than 70.0% of executives.

ClassificationRankingPercentile
All
4,190
out of 13,971
70th
Division
Manufacturing
1,527
out of 5,695
73rd
Major group
Chemicals And Allied Products
535
out of 2,194
76th
Industry group
Drugs
450
out of 1,880
76th
Industry
Pharmaceutical Preparations
345
out of 1,392
75th

Pay ratio

Andy Pasternak's Pay$2,924,542
Median Employee's Pay$250,565
Pay Ratio

to 1

In 2019, the annual total compensation of Andy Pasternak was $2,924,542.

The annual total compensation of the median employee at Horizon Pharma was $250,565.

The ratio of Andy Pasternak's pay to the pay of median employee was therefore to one.

Source: SEC filing on March 17, 2021.

Pasternak's colleagues

We found eight more compensation records of executives who worked with Andy Pasternak at Horizon Pharma in 2019.

2019

Timothy Walbert

Horizon Pharma

Chief Executive Officer

2019

Barry Moze

Horizon Pharma

Chief Administrative Officer

2019

Paul Hoelscher

Horizon Pharma

Chief Financial Officer

2019

Robert Carey

Horizon Pharma

Former Executive Vice President, Chief Business Officer

2019

Shao-Lee Lin

Horizon Pharma

Chief Scientific Officer

2019

Vikram Karnani

Horizon Pharma

Executive Vice President, Chief Commercial Officer

2019

Jeffrey FACP

Horizon Pharma

Chief Medical Officer

2019

Brian Beeler

Horizon Pharma

General Counsel

News

You may also like